ASPI ASP Isotopes Inc.
Miscellaneous Chemical Products · Nasdaq · SEC CIK 1921865 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY552.4%
TTM net income YoY-28.0%
TTM EPS YoY0.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin19.4%
Operating margin-400.9%
Net margin-435.3%
FCF margin-322.6%
EBITDA margin-382.6%
Returns
ROE-63.9%
ROA-35.4%
ROIC (approx.)-107.2%
Asset turnover0.08x
Leverage & solvency
Liabilities / assets33.2%
Debt / equity0.15x
Current ratio3.44x
Interest coverage-17.04x
Cash quality & payout
Operating cash flow / net income0.62x
Accruals ratio-13.4%
Payout ratio—
Capex / revenue51.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $5.12M | $5.12M | $4.18M | $16.66M | $1.27M | $1.20M | $1.10M | $1.19M |
| Cost of revenue | $4.33M | $3.64M | $2.51M | $14.58M | $1.03M | $626,000 | $775,000 | $588,141 |
| Gross profit | $793,000 | $1.48M | $1.67M | $2.08M | $242,000 | $572,000 | $327,000 | $605,737 |
| R&D expense | $7.24M | $6.82M | $5.26M | $6.85M | $3.10M | $880,000 | $1.53M | $1.42M |
| SG&A expense | $34.07M | $28.85M | $21.29M | $17.54M | $12.13M | $11.66M | $6.75M | $6.84M |
| Operating income | -$40.52M | -$34.20M | -$24.89M | -$25.02M | -$14.99M | -$11.97M | -$7.95M | -$7.65M |
| Interest expense | $3.48M | $1.77M | $1.73M | $330,000 | $76,000 | $82,000 | $87,000 | $85,168 |
| Pretax income | -$29.75M | -$34.09M | -$26.74M | -$63.15M | -$13.13M | -$75.06M | -$8.53M | -$9.07M |
| Income tax | $1.12M | -$97,000 | -$31,000 | $183,853 | $52,000 | $95,000 | -$71,000 | $153,669 |
| Net income | -$30.87M | -$33.99M | -$7.12M | -$63.33M | -$12.89M | -$75.16M | -$8.46M | -$9.22M |
| EBITDA | -$40.02M | -$32.99M | -$21.83M | -$24.08M | -$14.76M | -$11.44M | -$7.80M | -$7.60M |
| EPS (basic) | -0.21 | -0.27 | -0.06 | — | -0.14 | -1.03 | -0.12 | — |
| EPS (diluted) | -0.21 | -0.27 | -0.06 | — | -0.14 | -1.03 | -0.12 | — |
| Weighted avg. shares (diluted) | 143.39M | 122.72M | 121.00M | — | 88.55M | 73.01M | 69.48M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $201.66M | $219.60M | $207.35M | $279.57M | $105.00M | $67.68M | $55.97M | $61.89M |
| Short-term investments | $0 | $35.30M | $83.17M | $47.74M | — | — | — | $0 |
| Inventory | $1.52M | $1.53M | $1.37M | $1.10M | $1.37M | $1.05M | $342,688 | $66,000 |
| Current assets | $236.53M | $272.17M | $308.74M | $399.92M | $174.04M | $101.59M | $59.03M | $65.74M |
| PP&E, net | $41.73M | $42.13M | $91.80M | $33.29M | $30.93M | $27.60M | $25.38M | $22.35M |
| Goodwill | $6.46M | $6.47M | $6.39M | $5.18M | $6.85M | $3.36M | $3.26M | $3.17M |
| Intangibles | $594,000 | $634,000 | — | $675,000 | — | — | — | — |
| Total assets | $538.13M | $572.05M | $587.67M | $498.02M | $225.89M | $135.91M | $90.87M | $94.35M |
| Current liabilities | $68.67M | $70.28M | $70.37M | $32.70M | $28.32M | $6.90M | $8.18M | $7.06M |
| Short-term debt | $47.69M | $54.51M | $53.27M | $584,000 | $12.40M | — | — | $939,000 |
| Long-term debt | $5.27M | $5.26M | $5.06M | $1.47M | $1.53M | — | — | $1.44M |
| Total debt | $52.96M | $59.77M | $58.33M | $2.06M | $13.94M | — | — | $2.38M |
| Total liabilities | $178.84M | $297.26M | $288.65M | $235.12M | $129.29M | $107.60M | $45.15M | $43.18M |
| Shareholders' equity | $349.30M | $264.69M | $289.00M | $204.15M | $74.07M | $25.23M | $42.51M | $47.90M |
| Net debt | -$148.71M | -$159.83M | -$149.02M | -$277.52M | -$91.06M | — | — | -$59.51M |
| Shares outstanding | 155.83M | 130.15M | 125.90M | 111.68M | 93.38M | 83.91M | 72.07M | 72.07M |
| Cash flow statement | ||||||||
| Operating cash flow | -$25.36M | -$23.33M | -$17.76M | -$17.85M | -$8.86M | -$7.90M | -$3.17M | -$3.76M |
| Capital expenditure | $3.35M | $4.09M | $6.14M | $2.40M | $3.15M | $1.80M | $2.31M | $1.32M |
| Free cash flow | -$28.70M | -$27.42M | -$23.90M | -$20.25M | -$12.01M | -$9.70M | -$5.48M | -$5.08M |
| Investing cash flow | $38.11M | $39.95M | -$97.18M | -$75.18M | -$10.45M | -$31.75M | -$2.36M | -$3.02M |
| Financing cash flow | -$6.61M | -$2.50M | $43.17M | $264.12M | $56.70M | $51.01M | -$225,000 | $17.69M |
| Depreciation & amortization | $500,000 | $1.20M | $3.06M | $936,725 | $228,000 | $530,000 | $149,000 | $45,791 |
| Stock-based compensation | $9.60M | $4.54M | $4.41M | $5.22M | $4.48M | $4.43M | $1.89M | $2.26M |
| Dividends paid | — | — | — | $0 | $0 | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 20 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.